HomeBIOBV • HEL
add
Biohit Oyj
Nakaraang pagsara
€2.95
Sakop ng araw
€2.94 - €2.95
Sakop ng taon
€1.89 - €4.35
Market cap
36.50M EUR
Average na Volume
13.65K
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(EUR) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 3.45M | 4.93% |
Gastos sa pagpapatakbo | 1.70M | -3.93% |
Net na kita | 700.00K | 210.42% |
Net profit margin | 20.29 | 195.77% |
Kita sa bawat share | — | — |
EBITDA | 700.00K | 124.00% |
Aktuwal na % ng binabayarang buwis | 6.67% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(EUR) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 6.70M | -1.67% |
Kabuuang asset | 15.50M | 19.97% |
Kabuuang sagutin | 3.30M | -5.55% |
Kabuuang equity | 12.20M | — |
Natitirang share | 15.18M | — |
Presyo para makapag-book | 3.69 | — |
Return on assets | 10.48% | — |
Return on capital | 12.70% | — |
Cash Flow
Net change in cash
(EUR) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 700.00K | 210.42% |
Cash mula sa mga operasyon | 1.05M | 61.29% |
Cash mula sa pag-invest | 50.00K | 8.70% |
Cash mula sa financing | -50.00K | -1.01% |
Net change in cash | 950.00K | 45.59% |
Malayang cash flow | 325.00K | 362.22% |
Tungkol
Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care. Wikipedia
Itinatag
1988
Website
Mga Empleyado
46